Using Reporter Gene Assays to Screen and Identify Chemical Compounds that Modulate Estrogen Receptor Activity
Current Protocols · 2024
DOI: 10.1002/cpz1.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Masato Ooka und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland. Hauptthemen laut MEDLINE: Genes, Reporter, High-Throughput Screening Assays, Estrogen Receptor alpha. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Estrogen receptor alpha (ERα) is a nuclear receptor that is expressed mainly in the breast, uterus, and ovary, among several other organs. ERα plays important roles in reproduction, mammary gland formation, and glucose homeostasis. Disruption of ERα may result in adverse outcomes, such as cancer, impaired fertility, and abnormal fetal growth. Therefore, identifying compounds that modulate ERα is of great interest due to their potential‐endocrine disrupting capability and pharmaceutical applications. To rapidly test tens of thousands of compounds, high‐throughput screening assays are essential. Here, we describe high‐throughput screening methods, including plating and treatment of cells in 384‐well and 1536‐well plates and analysis of the resulting data. The two cell lines used, MCF7‐VM7Luc4E2 and HEK293‐ERα‐bla, have been described previously. MCF7‐VM7Luc4E2 cells are a stable luciferase reporter gene cell line expressing full‐length endogenous estrogen receptor in the MCF7 cell line background, and HEK293‐ERα‐bla cells stably express an ERα ligand‐binding domain/GAL4 DNA‐binding domain fusion regulating a UAS β‐lactamase reporter gene. These cell lines can be used to identify and confirm ERα modulators. Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Establishment of a high‐throughput ERα reporter gene assay with luminescence readout to identify activators and inhibitors of estrogen receptor α Basic Protocol 2 : Use of an orthogonal assay with fluorescence readout to confirm potential estrogen receptor activators or inhibitors
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
- University of California Davis, Davis, California.
ORCID-Profile: Menghang Xia
Förderung
- NIEHS NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Ooka, M., Sakamuru, S., Furlow, J. D., & Xia, M. (2024). Using Reporter Gene Assays to Screen and Identify Chemical Compounds that Modulate Estrogen Receptor Activity. Current Protocols. https://doi.org/10.1002/cpz1.70029
Vancouver
Ooka M, Sakamuru S, Furlow JD, Xia M. Using Reporter Gene Assays to Screen and Identify Chemical Compounds that Modulate Estrogen Receptor Activity. Current Protocols. 2024. doi:10.1002/cpz1.70029
BibTeX
@article{Ooka2024,
author = {Ooka, Masato and Sakamuru, Srilatha and Furlow, J David and Xia, Menghang},
title = {Using Reporter Gene Assays to Screen and Identify Chemical Compounds that Modulate Estrogen Receptor Activity},
journal = {Current Protocols},
year = {2024},
doi = {10.1002/cpz1.70029}
}
EUVIMED